<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Psoriatic Arthritis Clinical Algorithm</title>
    <link href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0/css/all.min.css" rel="stylesheet">
    <style>
        :root {
            --primary-bg: #f4f7f6;
            --text-color: #333;
            --card-shadow: 0 4px 6px rgba(0,0,0,0.1);
            
            /* Section Colors */
            --color-assess: #3498db;
            --color-diag: #9b59b6;
            --color-treat: #e67e22;
            --color-follow: #27ae60;
            
            /* Badge Colors */
            --severity-red: #e74c3c;
            --severity-amber: #f1c40f;
            --severity-green: #2ecc71;
        }

        body {
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
            margin: 0;
            padding: 0;
            background-color: var(--primary-bg);
            color: var(--text-color);
            display: flex;
            min-height: 100vh;
        }

        /* Sidebar Styling */
        .sidebar {
            width: 250px;
            background: white;
            padding: 20px;
            position: fixed;
            height: 100vh;
            border-right: 1px solid #ddd;
            display: flex;
            flex-direction: column;
            z-index: 1000;
        }

        .sidebar h2 {
            font-size: 1.2rem;
            margin-bottom: 20px;
            color: #2c3e50;
        }

        .progress-list {
            list-style: none;
            padding: 0;
        }

        .progress-item {
            padding: 10px;
            margin-bottom: 10px;
            border-radius: 5px;
            cursor: pointer;
            transition: all 0.3s ease;
            display: flex;
            align-items: center;
            font-size: 0.9rem;
            color: #7f8c8d;
        }

        .progress-item i {
            margin-right: 10px;
            width: 20px;
        }

        .progress-item.active {
            background-color: #ecf0f1;
            font-weight: bold;
            color: #2c3e50;
            border-left: 4px solid #2c3e50;
        }

        .progress-item.active.step-1 { border-color: var(--color-assess); color: var(--color-assess); }
        .progress-item.active.step-2 { border-color: var(--color-diag); color: var(--color-diag); }
        .progress-item.active.step-3 { border-color: var(--color-treat); color: var(--color-treat); }
        .progress-item.active.step-4 { border-color: var(--color-follow); color: var(--color-follow); }

        /* Main Content */
        .main-content {
            flex: 1;
            margin-left: 250px;
            padding: 40px;
            max-width: 900px;
        }

        .header-box {
            margin-bottom: 30px;
        }

        .header-box h1 {
            margin: 0;
            color: #2c3e50;
        }

        .header-box p {
            color: #7f8c8d;
        }

        /* Card System */
        .card {
            background: white;
            border-radius: 8px;
            box-shadow: var(--card-shadow);
            margin-bottom: 20px;
            overflow: hidden;
            transition: transform 0.2s ease;
            border-left: 5px solid #ccc;
        }

        .card:hover {
            transform: translateY(-2px);
        }

        /* Card Colors */
        .card.assess { border-color: var(--color-assess); }
        .card.diag { border-color: var(--color-diag); }
        .card.treat { border-color: var(--color-treat); }
        .card.follow { border-color: var(--color-follow); }

        .card-header {
            padding: 20px;
            cursor: pointer;
            display: flex;
            justify-content: space-between;
            align-items: center;
            background: linear-gradient(to right, #ffffff, #fdfdfd);
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            display: flex;
            align-items: center;
        }

        .card-title i {
            margin-right: 15px;
            padding: 10px;
            border-radius: 50%;
            color: white;
        }

        .assess .card-title i { background-color: var(--color-assess); }
        .diag .card-title i { background-color: var(--color-diag); }
        .treat .card-title i { background-color: var(--color-treat); }
        .follow .card-title i { background-color: var(--color-follow); }

        .card-toggle {
            transition: transform 0.3s ease;
        }

        .card-body {
            max-height: 0;
            overflow: hidden;
            transition: max-height 0.5s ease-out;
            padding: 0 20px;
            background-color: #fafafa;
        }

        .card.expanded .card-body {
            max-height: 2000px; /* Arbitrary large number for slide effect */
            padding: 20px;
            border-top: 1px solid #eee;
        }

        .card.expanded .card-toggle {
            transform: rotate(180deg);
        }

        /* Content Styling inside Cards */
        h3 { font-size: 1rem; color: #444; margin-top: 20px; }
        p, li { line-height: 1.6; font-size: 0.95rem; color: #555; }
        
        .citation {
            font-size: 0.75rem;
            color: #95a5a6;
            vertical-align: super;
        }

        /* Badges */
        .badge {
            padding: 4px 8px;
            border-radius: 12px;
            font-size: 0.75rem;
            font-weight: bold;
            color: white;
            margin-left: 10px;
            text-transform: uppercase;
        }
        .badge-red { background-color: var(--severity-red); }
        .badge-amber { background-color: var(--severity-amber); color: #333; }
        .badge-green { background-color: var(--severity-green); }

        /* Treatment Tabs */
        .tab-container {
            margin-top: 15px;
        }
        .tab-buttons {
            display: flex;
            gap: 10px;
            margin-bottom: 15px;
            flex-wrap: wrap;
        }
        .tab-btn {
            padding: 8px 16px;
            border: 1px solid #ddd;
            background: white;
            border-radius: 20px;
            cursor: pointer;
            transition: all 0.2s;
            font-size: 0.9rem;
        }
        .tab-btn.active {
            background-color: var(--color-treat);
            color: white;
            border-color: var(--color-treat);
        }
        .tab-content {
            display: none;
            background: white;
            padding: 15px;
            border-radius: 8px;
            border: 1px solid #eee;
        }
        .tab-content.active {
            display: block;
            animation: fadeIn 0.5s;
        }

        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }

        /* Mobile Responsive */
        @media (max-width: 768px) {
            .sidebar {
                display: none; /* Hidden on mobile for simplicity in this demo */
            }
            .main-content {
                margin-left: 0;
                padding: 20px;
            }
        }
    </style>
</head>
<body>

    <nav class="sidebar">
        <h2><i class="fas fa-notes-medical"></i> PsA Pathway</h2>
        <ul class="progress-list">
            <li class="progress-item step-1" onclick="scrollToCard('card-assess')">
                <i class="fas fa-search"></i> Assessment
            </li>
            <li class="progress-item step-2" onclick="scrollToCard('card-diag')">
                <i class="fas fa-stethoscope"></i> Diagnosis
            </li>
            <li class="progress-item step-3" onclick="scrollToCard('card-treat')">
                <i class="fas fa-pills"></i> Treatment
            </li>
            <li class="progress-item step-4" onclick="scrollToCard('card-follow')">
                <i class="fas fa-heartbeat"></i> Follow Up
            </li>
        </ul>
        <div style="margin-top: auto; font-size: 0.7rem; color: #999;">
            Based on BMJ Best Practice (2023)
        </div>
    </nav>

    <div class="main-content">
        
        <div class="header-box">
            <h1>Psoriatic Arthritis (PsA)</h1>
            <p>Interactive management algorithm. Click sections to expand.</p>
        </div>

        <div class="card assess" id="card-assess">
            <div class="card-header" onclick="toggleCard(this)">
                <div class="card-title">
                    <i class="fas fa-search"></i> Assessment & Suspicion
                </div>
                <div>
                    <span class="badge badge-amber">Screening</span>
                    <i class="fas fa-chevron-down card-toggle"></i>
                </div>
            </div>
            <div class="card-body">
                <h3>When to Suspect PsA</h3>
                <p>PsA occurs in around 25% of patients with psoriasis <span class="citation">[cite: 12]</span>. Recognition of inflammatory joint symptoms is the first step.</p>
                <ul>
                    <li><strong>Key Symptoms:</strong> Prolonged morning stiffness (>30 mins), first-step foot pain, tender/swollen joints <span class="citation">[cite: 120-123]</span>.</li>
                    <li><strong>Dactylitis:</strong> "Sausage digit" swelling, present in 40-50% of patients <span class="citation">[cite: 220]</span>.</li>
                    <li><strong>Nail Changes:</strong> Pitting or onycholysis (80-90% of patients) <span class="citation">[cite: 224]</span>.</li>
                </ul>
                <h3>Screening Tools</h3>
                <p>Use questionnaires like PEST, PASE, or ePASQ to identify PsA in psoriasis patients <span class="citation">[cite: 117]</span>.</p>
            </div>
        </div>

        <div class="card diag" id="card-diag">
            <div class="card-header" onclick="toggleCard(this)">
                <div class="card-title">
                    <i class="fas fa-stethoscope"></i> Diagnosis
                </div>
                <div>
                    <span class="badge badge-green">Clinical</span>
                    <i class="fas fa-chevron-down card-toggle"></i>
                </div>
            </div>
            <div class="card-body">
                <h3>Diagnostic Approach</h3>
                <p>Diagnosis is made clinically based on history and physical exam <span class="citation">[cite: 115]</span>. Most patients are seronegative.</p>
                
                <h3>CASPAR Criteria (â‰¥3 points) <span class="citation">[cite: 82]</span></h3>
                <ul>
                    <li>Current psoriasis (2 pts) or history/family history (1 pt).</li>
                    <li>Nail dystrophy (1 pt).</li>
                    <li>Negative Rheumatoid Factor (1 pt) <span class="citation">[cite: 85]</span>.</li>
                    <li>Dactylitis (current or history) (1 pt).</li>
                    <li>Juxta-articular new bone formation on X-ray (1 pt) <span class="citation">[cite: 93]</span>.</li>
                </ul>

                <h3>Investigations</h3>
                <ul>
                    <li><strong>Labs:</strong> ESR/CRP (markers of inflammation), negative RF/anti-CCP (to exclude RA) <span class="citation">[cite: 254]</span>.</li>
                    <li><strong>Imaging:</strong> Plain X-rays of hands/feet (erosions, periostitis) <span class="citation">[cite: 237]</span>. X-rays of spine/pelvis if axial symptoms suspected.</li>
                </ul>
            </div>
        </div>

        <div class="card treat" id="card-treat">
            <div class="card-header" onclick="toggleCard(this)">
                <div class="card-title">
                    <i class="fas fa-pills"></i> Management Algorithm
                </div>
                <div>
                    <span class="badge badge-red">Active Disease</span>
                    <i class="fas fa-chevron-down card-toggle"></i>
                </div>
            </div>
            <div class="card-body">
                <p>Treatment depends on the dominant clinical manifestation. Select a presentation below:</p>
                
                <div class="tab-container">
                    <div class="tab-buttons">
                        <button class="tab-btn active" onclick="openTab(event, 'peripheral')">Peripheral Arthritis</button>
                        <button class="tab-btn" onclick="openTab(event, 'axial')">Axial Disease</button>
                        <button class="tab-btn" onclick="openTab(event, 'enthesitis')">Enthesitis/Dactylitis</button>
                    </div>

                    <div id="peripheral" class="tab-content active">
                        <h3><i class="fas fa-hand-holding-medical"></i> Peripheral Arthritis</h3>
                        <h4>Step 1: Treatment Naive</h4>
                        <p><strong>Conventional Synthetic DMARD (csDMARD):</strong> Usually Methotrexate (preferred), Leflunomide, or Sulfasalazine <span class="citation">[cite: 288, 348]</span>.</p>
                        <p><em>Adjunct:</em> NSAIDs for symptoms <span class="citation">[cite: 285]</span>. Intra-articular steroid injections for oligoarthritis <span class="citation">[cite: 401]</span>.</p>
                        
                        <hr>
                        
                        <h4>Step 2: Inadequate Response</h4>
                        <p>If response is inadequate (3-6 months), escalate therapy <span class="citation">[cite: 288]</span>.</p>
                        <p><strong>Biological Agents (bDMARDs):</strong>
                            <ul>
                                <li><strong>TNF-alpha inhibitors:</strong> (e.g., Adalimumab, Etanercept) often first-line biologic <span class="citation">[cite: 292]</span>.</li>
                                <li><strong>IL-17 inhibitors:</strong> (e.g., Secukinumab, Ixekizumab) if relevant skin involvement or TNF contraindication <span class="citation">[cite: 381]</span>.</li>
                                <li><strong>IL-23 inhibitors:</strong> (e.g., Guselkumab).</li>
                                <li><strong>JAK inhibitors:</strong> (e.g., Tofacitinib) usually reserved for after biological failure <span class="citation">[cite: 306]</span>.</li>
                            </ul>
                        </p>
                    </div>

                    <div id="axial" class="tab-content">
                        <h3><i class="fas fa-spine"></i> Axial Disease</h3>
                        <p><span class="badge badge-amber">Note</span> csDMARDs (Methotrexate) are generally <strong>not effective</strong> for axial disease <span class="citation">[cite: 312]</span>.</p>
                        
                        <h4>Step 1: Initial Therapy</h4>
                        <p><strong>NSAIDs</strong> and physiotherapy <span class="citation">[cite: 314]</span>.</p>
                        
                        <h4>Step 2: Inadequate Response</h4>
                        <p>Escalate directly to Biological Agents:</p>
                        <ul>
                            <li><strong>TNF-alpha inhibitors</strong> or <strong>IL-17 inhibitors</strong> (Secukinumab/Ixekizumab) are recommended <span class="citation">[cite: 309, 310]</span>.</li>
                            <li><strong>JAK inhibitors</strong> are an option if NSAIDs fail <span class="citation">[cite: 314]</span>.</li>
                            <li>IL-12/23 and IL-23 inhibitors are <em>not</em> recommended for axial disease <span class="citation">[cite: 312]</span>.</li>
                        </ul>
                    </div>

                    <div id="enthesitis" class="tab-content">
                        <h3><i class="fas fa-bone"></i> Enthesitis & Dactylitis</h3>
                        
                        <h4>Dactylitis</h4>
                        <p>Associated with severe disease and radiographic progression <span class="citation">[cite: 316]</span>.</p>
                        <ul>
                            <li><strong>Initial:</strong> NSAIDs + Physiotherapy.</li>
                            <li><strong>Escalation:</strong> Biologics (TNF, IL-17, IL-12/23, JAK) are effective. Methotrexate may show some efficacy <span class="citation">[cite: 580]</span>.</li>
                        </ul>

                        <h4>Enthesitis</h4>
                        <ul>
                            <li><strong>Initial:</strong> NSAIDs are first-line <span class="citation">[cite: 516]</span>. Physiotherapy.</li>
                            <li><strong>Escalation:</strong> If NSAIDs fail, switch to Biologics (TNF, IL-17, IL-12/23, JAK) or Apremilast <span class="citation">[cite: 534]</span>.</li>
                        </ul>
                    </div>
                </div>
            </div>
        </div>

        <div class="card follow" id="card-follow">
            <div class="card-header" onclick="toggleCard(this)">
                <div class="card-title">
                    <i class="fas fa-heartbeat"></i> Follow Up & Prevention
                </div>
                <div>
                    <span class="badge badge-green">Long-term</span>
                    <i class="fas fa-chevron-down card-toggle"></i>
                </div>
            </div>
            <div class="card-body">
                <h3>Monitoring</h3>
                <p>Disease and drug monitoring recommended on a regular basis. Assess CRP, joint counts, and skin extent (BSA) at visits <span class="citation">[cite: 611]</span>.</p>
                
                <h3>Complications & Comorbidities</h3>
                <ul>
                    <li><strong>Cardiovascular Disease:</strong> Medium likelihood. Risk assessment recommended every 5 years <span class="citation">[cite: 614, 618]</span>.</li>
                    <li><strong>Metabolic Syndrome:</strong> Obesity and dyslipidaemia are common <span class="citation">[cite: 616]</span>.</li>
                    <li><strong>Infection:</strong> Biologicals increase risk. Screen for TB/Hepatitis B prior to initiation <span class="citation">[cite: 613]</span>.</li>
                </ul>
                
                <h3>Supportive Measures</h3>
                <p>Smoking cessation, weight loss, and low-impact exercise are strongly recommended <span class="citation">[cite: 390]</span>.</p>
            </div>
        </div>

    </div>

    <script>
        // Card Expansion Logic
        function toggleCard(header) {
            const card = header.parentElement;
            const body = card.querySelector('.card-body');
            const isActive = card.classList.contains('expanded');

            // Close all other cards (accordion style) - Optional
            /*
            document.querySelectorAll('.card').forEach(c => {
                c.classList.remove('expanded');
            });
            */

            if (isActive) {
                card.classList.remove('expanded');
            } else {
                card.classList.add('expanded');
            }
        }

        // Tab Switching Logic
        function openTab(evt, tabName) {
            var i, tabcontent, tablinks;
            
            // Hide all tab content
            tabcontent = document.getElementsByClassName("tab-content");
            for (i = 0; i < tabcontent.length; i++) {
                tabcontent[i].classList.remove('active');
            }

            // Remove active class from buttons
            tablinks = document.getElementsByClassName("tab-btn");
            for (i = 0; i < tablinks.length; i++) {
                tablinks[i].classList.remove("active");
            }

            // Show current tab and add active class to button
            document.getElementById(tabName).classList.add('active');
            evt.currentTarget.classList.add("active");
        }

        // Scroll to Card Logic
        function scrollToCard(cardId) {
            const element = document.getElementById(cardId);
            const offset = 20;
            const bodyRect = document.body.getBoundingClientRect().top;
            const elementRect = element.getBoundingClientRect().top;
            const elementPosition = elementRect - bodyRect;
            const offsetPosition = elementPosition - offset;

            window.scrollTo({
                top: offsetPosition,
                behavior: "smooth"
            });

            // Auto expand the target card
            const card = document.getElementById(cardId);
            if (!card.classList.contains('expanded')) {
                card.classList.add('expanded');
            }
        }

        // Highlight Sidebar on Scroll
        window.addEventListener('scroll', () => {
            const cards = document.querySelectorAll('.card');
            const navItems = document.querySelectorAll('.progress-item');
            
            let current = '';

            cards.forEach(card => {
                const cardTop = card.offsetTop;
                if (scrollY >= (cardTop - 200)) {
                    current = card.getAttribute('id');
                }
            });

            navItems.forEach(item => {
                item.classList.remove('active');
                if (current === 'card-assess' && item.classList.contains('step-1')) item.classList.add('active');
                if (current === 'card-diag' && item.classList.contains('step-2')) item.classList.add('active');
                if (current === 'card-treat' && item.classList.contains('step-3')) item.classList.add('active');
                if (current === 'card-follow' && item.classList.contains('step-4')) item.classList.add('active');
            });
        });
    </script>
</body>
</html>